SCHEMBL27634897

SCHEMBL27634897

O=CC(=O)c1ccccc2cccc1-2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.53
▸ GPR52 Q9Y2T5 1/20 0.50
▸ HNF4A P41235 1/20 0.50
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ CHRNB2 P17787 3/20 0.47
▸ CHRNB4 P30926 3/20 0.47
▸ CHRNA3 P32297 3/20 0.47
▸ CHRNA4 P43681 3/20 0.47
▸ ALDH1A1 P00352 4/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ TSHR P16473 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ HSP90AA1 P07900 1/20 0.43
▸ FABP3 P05413 1/20 0.42
▸ FABP4 P15090 1/20 0.42
▸ FABP5 Q01469 1/20 0.42
▸ HTT P42858 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7864455 0.96 BCAT2 (0.59) BCAT2GPR52HNF4AMEN1KMT2A
SCHEMBL11528273 0.84 HNF4A (0.49) BCAT2GPR52HNF4AMEN1KMT2A
Water SCHEMBL11409301 0.83 HNF4A (0.47) BCAT2GPR52HNF4AMEN1KMT2A
Water SCHEMBL11415614 0.83 HNF4A (0.47) BCAT2GPR52HNF4AMEN1KMT2A
SCHEMBL3627480 0.83 PDCD1 (0.47) BCAT2GPR52HNF4AMEN1KMT2A
SCHEMBL11530033 0.83 BCAT2 (0.46) BCAT2GPR52HNF4AMEN1KMT2A
SCHEMBL11525121 0.81 BRS3 (0.46) BCAT2GPR52SMN1; SMN2ALDH1A1HTT
SCHEMBL420969 0.79 ALDH1A1 (0.59) SMN1; SMN2ALDH1A1MAPK1TDP1TSHR
SCHEMBL10951356 0.78 ALDH1A1 (0.47) HNF4AMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL5180034 0.78 BCAT2 (0.57) BCAT2GPR52HNF4AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101142226-A Tricyclic-nucleoside prodrugs for treating viral infections GENELABS TECH INC (US) 2008-03-12 — — CN claimed
CN-102592040-B The method of drug discovery 基德姆生物科学有限公司 2016-12-21 — — CN disclosed
CN-101142226-A Tricyclic-nucleoside prodrugs for treating viral infections GENELABS TECH INC (US) 2008-03-12 — — CN disclosed
CN-1668918-A Methods of Drug Discovery KEDDEM BIO SCIENCE LTD (IL) 2005-09-14 — — CN disclosed
Send feedback